SALICYLIC ACID - Longway Technology(Guangzhou)Co., Ltd.
- Manufacturer
- Longway Technology(Guangzhou)Co., Ltd.
- Effective date
- 2026-06-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-08-13 01:01:08
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
SALICYLIC ACID 1.0%
INACTIVE INGREDIENT SECTION
WATER,PROPANEDIOL,NIACINAMIDE,GLUCONOLACTONE,POLYACRYLATE CROSSPOLYMER-6,SODIUM HYDROXIDE,PHENOXYETHANOL,BETAINE,SODIUM DEXTRAN SULFATE,PEG-40 HYDROGENATED CASTOR OIL,ZINC PCA,SUCCINIC ACID,DISODIUM EDTA,ETHYLHEXYLGLYCERIN,O-CYMEN-5-OL,MENTHOL,BENZOPHENONE-4
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
If swllowed get medical help or contact a Poison Control Center right away.
WARNINGS SECTION
· For external use only
Stop use and ask a doctor· if skin irritation occurs or gets worse
· side effects occur.You may report side effects to FDA at 1-800-FDA-1088.
· When using this product
· skin irritation and drynessis more likely to occur if you use another topical acne medication at the same time. If iritation occurs,only use one topical acne medication at a time.Rinse right away with waterifit gets in eyes.
·
Keep out of reachof children
·If swallowed get medical help or contact a Poison Control Centerright away.
OTC - PURPOSE SECTION
Treatment of acne
INDICATIONS & USAGE SECTION
·For the treatment ofacne.
·Helps prevent new acne blemishes from forming.
·Clears up acne blemishes and allows skin to heal.
DOSAGE & ADMINISTRATION SECTION
· Clean the skin thoroughly before applying this product·
· Cover the entire affected area with a thin layer one to three times daily
· Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
·If bother some dryness or peeling occurs, reduce applica-tion to once a day or every other day.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 4897147692627 | GTIN-13: 4897147692627 EAN-13: 4897147692627 GTIN storage (14 digits): 04897147692627 | 01.jpg |
Products#
Every source-derived product name is available through these pages.
- SKINTIFIC 3X ACID INTENSIVE ACNE TREATMENT
- SALICYLIC ACID
- WATER
- PROPANEDIOL
- NIACINAMIDE
- GLUCONOLACTONE
- POLYACRYLATE CROSSPOLYMER-6
- SODIUM HYDROXIDE
- PHENOXYETHANOL
- BETAINE
- PEG-40 HYDROGENATED CASTOR OIL
- ZINC PCA
- SUCCINIC ACID
- EDETATE DISODIUM
- ETHYLHEXYLGLYCERIN
- O-CYMEN-5-OL
- MENTHOL
- BENZOPHENONE-4
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85161-176 | 85161-176-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| WATER | 059QF0KO0R | IACT |
| PROPANEDIOL | 5965N8W85T | IACT |
| NIACINAMIDE | 25X51I8RD4 | IACT |
| GLUCONOLACTONE | WQ29KQ9POT | IACT |
| POLYACRYLATE CROSSPOLYMER-6 | Q7UI015FF9 | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| BETAINE | 3SCV180C9W | IACT |
| PEG-40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | IACT |
| ZINC PCA | C32PQ86DH4 | IACT |
| SUCCINIC ACID | AB6MNQ6J6L | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| ETHYLHEXYLGLYCERIN | 147D247K3P | IACT |
| O-CYMEN-5-OL | H41B6Q1I9L | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| BENZOPHENONE-4 | 1W6L629B4K | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SKINTIFIC 3X ACID INTENSIVE ACNE TREATMENT | SALICYLIC ACID | Longway Technology(Guangzhou)Co., Ltd. | 553957ef-cb8a-e75d-e063-6394a90a261b | 2026-06-27 | Warnings | 85161-176-01 85161-176 85161017601 553957ef-cb8b-e75d-e063-6394a90a261b 553957ef-cb8a-e75d-e063-6394a90a261b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
